Solventum Corporation (SOLV)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.96 (-1.36%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Solventum Corporation (SOLV)
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.

Key Insights

Critical company metrics and information
  • Share Price

    $69.55
  • Market Cap

    $12.02 Billion
  • Total Outstanding Shares

    172.76 Million Shares
  • Total Employees

    22,000
  • Dividend

    No dividend
  • IPO Date

    March 26, 2024
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Homepage

    https://www.3m.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities$-93.00 Million
Net Cash Flow From Financing Activities, Continuing$-202.00 Million
Net Cash Flow$-126.00 Million
Net Cash Flow, Continuing$-126.00 Million
Net Cash Flow From Operating Activities, Continuing$169.00 Million
Net Cash Flow From Investing Activities, Continuing$-93.00 Million
Net Cash Flow From Operating Activities$169.00 Million
Net Cash Flow From Financing Activities$-202.00 Million

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Basic Average Shares$173.40 Million
Gross Profit$1.17 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Net Income/Loss Attributable To Parent$122.00 Million
Income Tax Expense/Benefit$45.00 Million
Revenues$2.08 Billion
Costs And Expenses$1.81 Billion
Net Income/Loss Available To Common Stockholders, Basic$122.00 Million
Selling, General, and Administrative Expenses$701.00 Million
Diluted Average Shares$173.90 Million
Income/Loss From Continuing Operations Before Tax$167.00 Million
Diluted Earnings Per Share$0.70
Research and Development$189.00 Million
Benefits Costs and Expenses$1.92 Billion
Operating Expenses$890.00 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income Tax Expense/Benefit, Deferred$-37.00 Million
Cost Of Revenue$917.00 Million
Basic Earnings Per Share$0.70
Net Income/Loss$122.00 Million
Income/Loss From Continuing Operations After Tax$122.00 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Operating Income/Loss$275.00 Million

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Other Non-current Assets$7.14 Billion
Intangible Assets$2.65 Billion
Equity$3.19 Billion
Wages$251.00 Million
Long-term Debt$8.11 Billion
Other Non-current Liabilities$540.00 Million
Noncurrent Assets$11.39 Billion
Assets$14.74 Billion
Noncurrent Liabilities$8.65 Billion
Inventory$953.00 Million
Fixed Assets$1.60 Billion
Other Current Assets$2.40 Billion
Current Assets$3.35 Billion
Other Current Liabilities$2.09 Billion
Equity Attributable To Parent$3.19 Billion
Equity Attributable To Noncontrolling Interest$0.00
Liabilities And Equity$14.74 Billion
Liabilities$11.55 Billion
Accounts Payable$560.00 Million
Current Liabilities$2.90 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.